Home/Filings/4/0001878313-25-000063
4//SEC Filing

Smith Stan 4

Accession 0001878313-25-000063

CIK 0001878313other

Filed

Dec 8, 7:00 PM ET

Accepted

Dec 9, 4:51 PM ET

Size

9.4 KB

Accession

0001878313-25-000063

Insider Transaction Report

Form 4
Period: 2025-12-05
Smith Stan
Director
Transactions
  • Purchase

    Common Stock

    2025-12-05$1.20/sh+4,580$5,4954,580 total(indirect: See footnote)
Holdings
  • Common Stock

    (indirect: See Footnote)
    1,364,289
Footnotes (4)
  • [F1]These securities are beneficially owned by Mr. Smith through the Travis Deo Zai Zai Smith IL Unif Trns Min Act. They are beneficially owned by Mr. Smith's family member. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  • [F2]These securities are beneficially owned by Mr. Smith through the Gage Quentin Smith IL Unif Trns Min Act. They are beneficially owned by Mr. Smith's family member. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  • [F3]These securities are beneficially owned by Mr. Smith through the Blake Sarai Teitei Smith IL Unif Trns Min Act. They are beneficially owned by Mr. Smith's family member. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  • [F4]These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

Issuer

MAIA Biotechnology, Inc.

CIK 0001878313

Entity typeother

Related Parties

1
  • filerCIK 0001913199

Filing Metadata

Form type
4
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 4:51 PM ET
Size
9.4 KB